| Product Code: ETC7916830 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia continued to import novel drug delivery systems primarily from the Netherlands, Lithuania, Germany, Belgium, and China. Despite a slight decline in the Compound Annual Growth Rate (CAGR) from 2020-2024 at -0.44%, there was a notable growth rate of 24.14% from 2023-2024. The Herfindahl-Hirschman Index (HHI) indicated a high concentration of imports among these top exporting countries, suggesting a competitive market landscape. Latvia`s reliance on these key suppliers reflects a strategic approach to access cutting-edge drug delivery technologies for the healthcare sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Novel Drug Delivery Systems Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Novel Drug Delivery Systems Market Revenues & Volume, 2022 & 2032F |
3.3 Latvia Novel Drug Delivery Systems Market - Industry Life Cycle |
3.4 Latvia Novel Drug Delivery Systems Market - Porter's Five Forces |
3.5 Latvia Novel Drug Delivery Systems Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.6 Latvia Novel Drug Delivery Systems Market Revenues & Volume Share, By Mode of NDDS, 2022 & 2032F |
4 Latvia Novel Drug Delivery Systems Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Latvia |
4.2.2 Growing demand for targeted drug delivery systems |
4.2.3 Technological advancements in drug delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for novel drug delivery systems |
4.3.2 High development costs associated with novel drug delivery technologies |
5 Latvia Novel Drug Delivery Systems Market Trends |
6 Latvia Novel Drug Delivery Systems Market, By Types |
6.1 Latvia Novel Drug Delivery Systems Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Route of Administration, 2022 - 2032F |
6.1.3 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Oral Drug Delivery Systems, 2022 - 2032F |
6.1.4 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Injectable Drug Delivery Systems, 2022 - 2032F |
6.1.5 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Pulmonary Drug Delivery Systems, 2022 - 2032F |
6.1.6 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Transdermal Drug Delivery Systems, 2022 - 2032F |
6.1.7 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Other Routes of Administration, 2022 - 2032F |
6.2 Latvia Novel Drug Delivery Systems Market, By Mode of NDDS |
6.2.1 Overview and Analysis |
6.2.2 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Targeted Drug Delivery Systems, 2022 - 2032F |
6.2.3 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Controlled Drug Delivery Systems, 2022 - 2032F |
6.2.4 Latvia Novel Drug Delivery Systems Market Revenues & Volume, By Modulated Drug Delivery Systems, 2022 - 2032F |
7 Latvia Novel Drug Delivery Systems Market Import-Export Trade Statistics |
7.1 Latvia Novel Drug Delivery Systems Market Export to Major Countries |
7.2 Latvia Novel Drug Delivery Systems Market Imports from Major Countries |
8 Latvia Novel Drug Delivery Systems Market Key Performance Indicators |
8.1 Adoption rate of novel drug delivery systems by healthcare facilities in Latvia |
8.2 Rate of research and development investment in novel drug delivery technologies |
8.3 Number of patents filed for novel drug delivery systems in Latvia |
9 Latvia Novel Drug Delivery Systems Market - Opportunity Assessment |
9.1 Latvia Novel Drug Delivery Systems Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.2 Latvia Novel Drug Delivery Systems Market Opportunity Assessment, By Mode of NDDS, 2022 & 2032F |
10 Latvia Novel Drug Delivery Systems Market - Competitive Landscape |
10.1 Latvia Novel Drug Delivery Systems Market Revenue Share, By Companies, 2025 |
10.2 Latvia Novel Drug Delivery Systems Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here